Literature DB >> 8326221

Mast cell quantitation in nasal polyps, sinus mucosa and nasal turbinate mucosa.

H Otsuka1, K Ohkubo, H Seki, M Ohnishi, T Fujikura.   

Abstract

The distribution and abundance of mast cells in nasal polyps, the maxillary sinus mucosa of patients with sinusitis and the turbinate mucosa of allergic rhinitis was microscopically examined using different methods of fixation. In the epithelium of the surface and the ducts of nasal polyps (n = 8), the mean number of mast cells was over 20,000 per mm3 using Mota's fixation and the increase was correlated with the epithelial thickness (P < 0.05). On the other hand those of the maxillary sinus mucosa (n = 6) and the nasal turbinate mucosa (n = 7) were less than 6,000 per mm3. In the subepithelial layer or areas deeper than the area with the glands, however, mast cell counts were less than 3,200 per mm3 in all diseases. More than 70-90 per cent of all mast cells in the epithelium of the mucosal surface and the ducts of the polyp, the maxillary sinus mucosa and nasal turbinates were formalin sensitive. Most of the mast cells in the subepithelial and deeper areas were formalin resistant in all diseases. These results suggest that conditions for mast cell growth differ between polyps and the other diseases, and that the conditions which affect mast cells may contribute to polyp development.

Entities:  

Mesh:

Year:  1993        PMID: 8326221     DOI: 10.1017/s002221510012331x

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Mast cell quantitation in non- neoplastic polypoidal nasal lesions.

Authors:  Vijaya V Mysorekar; Chitralekha P Dandekar; Saraswati G Rao
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-04

2.  Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue.

Authors:  Joke Patou; Gabriele Holtappels; Karen Affleck; Philippe Gevaert; Claudina Perez-Novo; Paul Van Cauwenberge; Claus Bachert
Journal:  J Inflamm (Lond)       Date:  2009-04-20       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.